Skip to main content
SpringerLink
Log in
Book cover

Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer pp 87–102Cite as

Early Stage Breast Cancer

  • Chapter
  • First Online:

  • 2235 Accesses

Abstract

In the multimodality treatment of breast cancer, adjuvant radiotherapy has an important role in achieving excellent local control and increasing survival. It has been easier to confirm the role of radiotherapy for local control [1, 2]; whereas it took decades to show that adjuvant radiotherapy also increased the survival rates [3, 4]. In this chapter, trials and meta-analysis of postoperative adjuvant radiotherapy for invasive early-stage breast cancer in the both settings of breast conservation therapy (BCT) and after mastectomy (postmastectomy radiotherapy [PMRT]) will be summarized; local control vs. survival issues will be discussed. Discussions related to cases of in situ ductal carcinoma, techniques of radiotherapy, side effects and complications, and management of locally advanced breast cancer can be found elsewhere.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat. 1987;71:15–29.

    CAS  Google Scholar 

  2. Early Breast Cancer Trialists’ Collaborative Group. Favorable and unfavorable effects on long term survival of radiotherapy for early breast cancer. Lancet. 2000;355:1757–70.

    Article  Google Scholar 

  3. Whelan TJ, Julian J, Wright J, et al. Does loco regional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 2000;18:1220–9.

    PubMed  CAS  Google Scholar 

  4. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087–106.

    Google Scholar 

  5. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456–61.

    Article  PubMed  CAS  Google Scholar 

  6. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments. J Natl Cancer Inst. 1995;87:19–27.

    Article  PubMed  CAS  Google Scholar 

  7. Jacobson J, Danforth D, Cowan K, et al. Ten year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907–11.

    Article  PubMed  CAS  Google Scholar 

  8. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long term results of three randomised trials on 1973 patients. Eur J Cancer. 1995;31A:1574–9.

    Article  PubMed  CAS  Google Scholar 

  9. Sarrazin D, Le M, Rousse J, et al. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 milimeters or less. The experience of the Institut Gustave-Roussy. Cancer. 1984;53:1209–13.

    Article  PubMed  CAS  Google Scholar 

  10. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  11. Veronesi U, Marubini E, Mariani Galimberti V, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001; 12:997–1003.

    Article  PubMed  CAS  Google Scholar 

  12. Van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–50.

    Article  PubMed  Google Scholar 

  13. The START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.

    Article  Google Scholar 

  14. Veronesi U, Luini A, Galimberti V, Zurrida S. Conservation approaches for the management of stage I-II carcinoma of the breast. Milan Cancer Institute Trials. World J Surg. 1994;18:70–5.

    Article  PubMed  CAS  Google Scholar 

  15. Liljegren G, Holmberg L, Adami HO, et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer. Five-years results of a randomized trial. J Natl Cancer Inst. 1994;86:717–22.

    Article  PubMed  CAS  Google Scholar 

  16. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol. 1999;17:2326–33.

    PubMed  CAS  Google Scholar 

  17. Whelan T, Clark R, Roberts R, et al. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Int J Radiat Oncol Biol Phys. 1994;30:11–6.

    Article  PubMed  CAS  Google Scholar 

  18. Winzer KJ, Sauer R, Sauerbrei W, et al. Radiation therapy after breast-conserving surgery: first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer. 2004; 40:998–1005.

    Article  PubMed  Google Scholar 

  19. Haffty BG, Buchholz TA, Perez CA. Early stage breast cancer. In: Halperin EC, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 1175–291.

    Google Scholar 

  20. Schnitt SJ, Hayman J, Gelman R, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer. 1996;77:1094–100.

    Article  PubMed  CAS  Google Scholar 

  21. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early stage breast cancer. N Engl J Med. 2004;351:963–70.

    Article  PubMed  CAS  Google Scholar 

  22. Hughes KS, Schnaper LA, Berry D, et al. Cancer and Leukemia Group B; Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–978.

    Google Scholar 

  23. Fisher B, Bryant J, Dignam JJ, et al. National Surgical Adjuvant Breast and Bowel Project. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141–4149.

    Google Scholar 

  24. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25:3259–65.

    Article  PubMed  Google Scholar 

  25. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15:963–8.

    PubMed  CAS  Google Scholar 

  26. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standart radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–87.

    Article  PubMed  CAS  Google Scholar 

  27. Poortmans P, Bartelink H, Horiot JC, et al. EORTC Radiotherapy and Breast Cancer Group. The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial. Radiother Oncol. 2004;72:25–33.

    Google Scholar 

  28. DiBiase SJ, Komarnicky LT, Heron DE, et al. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phys. 2002;53:680–6.

    Article  PubMed  Google Scholar 

  29. Vicini FA, Goldstein NS, Pass H, et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2004;60:86–94.

    Article  PubMed  Google Scholar 

  30. Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risk of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004;96:115–21.

    Article  PubMed  Google Scholar 

  31. Early Breast Trialists’ Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10801 women in 17 randomised trials. Lancet. 2011;378:1707–16.

    Google Scholar 

  32. Rose MA, Olivotto I, Cady B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg. 1989;124:153–7.

    Article  PubMed  CAS  Google Scholar 

  33. Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC “boost vs. no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol. 2000; 55:219–32.

    Article  PubMed  CAS  Google Scholar 

  34. Brose MS, Rebbeck TR, Calzone KA, et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst. 2002;94:1365–72.

    Article  PubMed  CAS  Google Scholar 

  35. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.

    Article  PubMed  CAS  Google Scholar 

  36. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–92.

    Article  PubMed  CAS  Google Scholar 

  37. Robson M, Levin D, Federici M, et al. Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst. 1999;91:2112–7.

    Article  PubMed  CAS  Google Scholar 

  38. Pierce LJ, Levin AM, Rebbeck TR, et al. Ten year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2 associated stage I/II breast cancer. J Clin Oncol. 2006;24:2437–43.

    Article  PubMed  Google Scholar 

  39. Haffty BG, Harrold E, Khan AJ, et al. Outcome of conservatively managed early-onset breast cancer by BRCA 1/2 status. Lancet. 2002;359:1471–7.

    Article  PubMed  Google Scholar 

  40. Pierce LJ, Phillips K-A, Griffith KA, et al. Local therapy in BRCA 1/2 carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat. 2010;121:389–98.

    Article  PubMed  Google Scholar 

  41. Pierce LJ, Strawderman M, Narod SA, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol. 2000; 18:3360–9.

    PubMed  CAS  Google Scholar 

  42. Shanley S, McReynolds K, Ardern-Jones A, et al. Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clin Cancer Res. 2006;23:7025–32.

    Article  Google Scholar 

  43. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55.

    Article  PubMed  CAS  Google Scholar 

  44. Ragaz J, Jackson SM, Le N, Plenderleith IH, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–62.

    Article  PubMed  CAS  Google Scholar 

  45. Gebski V, Lagleva M, Keech A, et al. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses; a clinical perspective. J Natl Cancer Inst. 2006;98: 26–38.

    Article  PubMed  Google Scholar 

  46. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol. 2000;55:263–72.

    Article  PubMed  Google Scholar 

  47. Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement; adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst. 2001;93:979–89.

    Article  PubMed  CAS  Google Scholar 

  48. Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes, dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus 2011. Ann Oncol. 2011;22:1736–47.

    Article  PubMed  CAS  Google Scholar 

  49. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–69.

    PubMed  CAS  Google Scholar 

  50. Harris JR, Halpin-Murphy P, McNeese M, et al. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:989–90.

    Article  PubMed  CAS  Google Scholar 

  51. Kurtz J. EUSOMA Working Party. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer. 2002;38:1961–74.

    Article  PubMed  CAS  Google Scholar 

  52. Belkacemi Y, Fourquet A, Cutuli B, et al. Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint Paul de Vence. Crit Rev Oncol Hematol. 2010;79:91–102.

    Google Scholar 

  53. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82b and 82c randomised trials. Radiother Oncol. 2007;82: 247–53.

    Article  PubMed  Google Scholar 

  54. Van der Hage JA, Putter H, Bonnema J. Impact of locoregional treatment on the early stage breast cancer patients: a retrospective analysis. Eur J Cancer. 2003;39:2192–9.

    Article  PubMed  Google Scholar 

  55. Overgaard M, Jensen MB, Overgaard J. Randomized trial evaluating postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen. Results from the DBCG 82c trial. Lancet. 1999;353:1641–8.

    Article  PubMed  CAS  Google Scholar 

  56. Recht A, Gray R, Davidson N, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–700.

    PubMed  CAS  Google Scholar 

  57. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 2000;18:2817–27.

    PubMed  CAS  Google Scholar 

  58. Wallgren A, Bonetti M, Gelber RD, et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I-VIII. J Clin Oncol. 2003;21:1205–13.

    Article  PubMed  CAS  Google Scholar 

  59. Taghian A, Jeong J-H, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. J Clin Oncol. 2004;22:4247–54.

    Article  PubMed  Google Scholar 

  60. Sharma R, Bedrosian I, Lucci A, Hwang, et al. Present day locoregional control in patients with T1-2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol. 2010;17:2899–908.

    Google Scholar 

  61. Matzinger O, Heimsoth I, Poortmans P, et al. Toxicity at three years with and without irradiation of the internal mammary and medical supraclavicular lymph node chain in stage I to III breast cancer (EORTC Trial 22922/10925). Acta Oncol. 2010;49:24–34.

    Article  PubMed  Google Scholar 

  62. Whelan TJ, Olivotto I, Ackerman I, et al. NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol. 2011;29:80s (suppl 15; abstr LBA 1003).

    Google Scholar 

  63. Olsen NK, Pfeiffer P, Johannsen L, et al. Radiation induced brachial plexopathy. Neurological follow up in 161 recurrence free breast cancer patient. Int J Radiat Oncol Biol Phys. 1993;26: 43–9.

    Article  PubMed  CAS  Google Scholar 

  64. Dewar JA, Sarrazin D, Benhamou E, et al. Management of the axilla in conservatively treated breast cancer. 592 patient treated at Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1987;13:475–81.

    Article  PubMed  CAS  Google Scholar 

  65. Xie L, Higginson DS, Marks LB. Elective regional nodal irradiation in patient with early-stage breast cancer. Semin Radiat Oncol. 2010;21:66–78.

    Article  Google Scholar 

  66. Haffty BG, Hunt KK, Harris J, Buchholz TA. Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol. 2011;29:4479–81.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istanbul University Oncology Institute, Capa, Istanbul, 34390, Turkey

    Maktav Dincer

Authors
  1. Maktav Dincer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maktav Dincer .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Department of Radiation Oncology, Ege University, Ege Unv. Hastanesi, Izmir, 35100, Turkey

    Ayfer Haydaroglu

  2. Faculty of Medicine, Department of Radiation Oncology, Hacettepe University, Hacettepe Hastanesi, Ankara, 06100, Turkey

    Gokhan Ozyigit

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dincer, M. (2013). Early Stage Breast Cancer. In: Haydaroglu, A., Ozyigit, G. (eds) Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5116-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5116-7_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5115-0

  • Online ISBN: 978-1-4614-5116-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation